Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer Meeting Abstract


Authors: Tanioka, M.; Fan, C.; Carey, L. A.; Hyslop, T.; Pitcher, B. N.; Parker, J. A.; Hoadley, K. A.; Henry, N. L.; Tolaney, S.; Dang, C.; Krop, I. E.; Harris, L.; Berry, D. A.; Mardis, E.; Perou, C. M.; Winer, E. P.; Hudis, C. A.
Abstract Title: Integrated analysis of multidimensional genomic data on CALGB 40601 (Alliance), a randomized neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without lapatinib (L) for HER2-positive breast cancer
Meeting Title: 2016 San Antonio Breast Cancer Symposium (SABCS)
Journal Title: Cancer Research
Volume: 77
Issue: 4 Suppl.
Meeting Dates: 2016 Dec 6-10
Meeting Location: San Antonio, TX
ISSN: 0008-5472
Publisher: American Association for Cancer Research  
Date Published: 2017-02-01
Language: English
ACCESSION: WOS:000397999003016
DOI: 10.1158/1538-7445.sabcs16-s3-05
PROVIDER: wos
Notes: Meeting Abstract: S3-05 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Clifford Hudis
    906 Hudis
  2. Chau Dang
    273 Dang